This accords well with our original hypothesis (supported by our comprehensive analyses of CYP-derived metabolites in kidney and LV tissue) that pharmacological enhancement of EETs actions should attenuate HF in ACF TGR, which might have substantial implications for the treatment of HF. This evidence concerns the gene PPIG and hydrops fetalis.